搜尋





搜尋





Oric Pharmaceuticals Inc

ORIC

添加自選

13.350USD

+0.020+0.15%

交易中 09/24, 15:03（美東）

1.38B總市值

虧損本益比TTM

Oric Pharmaceuticals Inc

13.350

+0.020+0.15%

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

ORIC 利潤表

您可以在這裡找到Oric Pharmaceuticals Inc的年度或季度收入報告，以深入了解Oric Pharmaceuticals Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

營業費用

15.95%45.30M

21.09%39.62M

-12.68%34.55M

-4.30%36.67M

8.46%39.06M

12.86%32.72M

25.91%39.57M

33.60%38.32M

44.11%36.02M

12.90%28.99M

42.09%31.43M

38.60%28.68M

20.76%24.99M

10.41%25.68M

-3.01%22.12M

12.13%20.69M

-1.71%20.70M

40.51%23.26M

38.97%22.80M

46.12%18.46M

89.31%21.06M

80.34%16.55M

87.09%16.41M

77.98%12.63M

75.03%11.12M

44.64%9.18M

--8.77M

--7.10M

--6.36M

--6.35M

研發費用

18.81%36.30M

27.59%31.44M

-19.12%25.86M

-7.78%28.77M

5.56%30.55M

12.20%24.64M

30.59%31.97M

39.37%31.20M

54.04%28.94M

12.52%21.96M

50.24%24.48M

52.06%22.39M

35.80%18.79M

15.97%19.52M

-2.69%16.30M

14.14%14.72M

-10.85%13.83M

43.87%16.83M

38.24%16.75M

46.06%12.90M

100.92%15.52M

61.25%11.70M

74.04%12.11M

56.80%8.83M

53.23%7.72M

39.18%7.25M

--6.96M

--5.63M

--5.04M

--5.21M

折舊攤銷及損耗

-14.84%264.00K

-10.60%270.00K

5.26%320.00K

6.67%288.00K

13.97%310.00K

15.71%302.00K

15.59%304.00K

5.06%270.00K

5.02%272.00K

3.16%261.00K

6.48%263.00K

16.29%257.00K

4.86%259.00K

0.80%253.00K

7.86%247.00K

1.84%221.00K

11.26%247.00K

9.61%251.00K

-2.14%229.00K

-9.58%217.00K

-9.76%222.00K

-8.40%229.00K

-13.33%234.00K

-11.11%240.00K

0.00%246.00K

3.31%250.00K

--270.00K

--246.00K

--242.00K

營業利潤

-15.95%-45.30M

-21.09%-39.62M

12.68%-34.55M

4.30%-36.67M

-8.46%-39.06M

-12.86%-32.72M

-25.91%-39.57M

-33.60%-38.32M

-44.11%-36.02M

-12.90%-28.99M

-42.09%-31.43M

-38.60%-28.68M

-20.76%-24.99M

-10.41%-25.68M

3.01%-22.12M

-12.13%-20.69M

1.71%-20.70M

-40.51%-23.26M

-38.97%-22.80M

-46.12%-18.46M

-89.31%-21.06M

-80.34%-16.55M

-87.09%-16.41M

-77.98%-12.63M

-75.03%-11.12M

-44.64%-9.18M

---8.77M

---7.10M

---6.36M

---6.35M

淨非營業利息收入（費用）

利息收入

40.42%3.80M

42.83%3.85M

24.00%4.05M

8.85%4.08M

-33.18%2.71M

-32.22%2.70M

5.33%3.26M

17.10%3.75M

97.95%4.05M

129.60%3.98M

143.55%3.10M

270.40%3.20M

400.73%2.05M

1650.51%1.73M

3641.18%1.27M

2783.33%865.00K

1139.39%409.00K

125.00%99.00K

13.33%34.00K

200.00%30.00K

32.00%33.00K

-81.74%44.00K

-91.25%30.00K

-97.90%10.00K

-92.11%25.00K

-7.66%241.00K

--343.00K

--476.00K

--317.00K

--261.00K

特殊收入（費用）

----

--0.00

100.00%0.00

----

--0.00

---5.00M

----

100.00%0.00

----

---11.87M

---12.97M

----

--0.00

----

其他非經營性收入（費用）

--3.80M

----

--4.08M

----

-100.00%0.00

----

100.00%0.00

-100.00%0.00

-79.73%15.00K

-100.00%0.00

-109.46%-7.00K

-38.89%44.00K

1.37%74.00K

-5.71%66.00K

--74.00K

--72.00K

--73.00K

--70.00K

稅前利潤

-14.13%-41.49M

-19.14%-35.77M

15.98%-30.50M

5.73%-32.59M

-13.74%-36.35M

-20.03%-30.02M

-28.16%-36.31M

-35.67%-34.57M

-39.31%-31.96M

-4.45%-25.01M

-35.89%-28.33M

-2.61%-25.48M

-13.10%-22.94M

-3.39%-23.95M

8.45%-20.85M

-34.75%-24.83M

3.44%-20.29M

-40.28%-23.16M

19.42%-22.77M

27.88%-18.43M

-90.58%-21.01M

-86.08%-16.51M

-238.27%-28.26M

-290.11%-25.55M

-84.81%-11.02M

-47.50%-8.87M

---8.35M

---6.55M

---5.96M

---6.01M

除稅後利潤

-14.13%-41.49M

-19.14%-35.77M

15.98%-30.50M

5.73%-32.59M

-13.74%-36.35M

-20.03%-30.02M

-28.16%-36.31M

-35.67%-34.57M

-39.31%-31.96M

-4.45%-25.01M

-35.89%-28.33M

-2.61%-25.48M

-13.10%-22.94M

-3.39%-23.95M

8.45%-20.85M

-34.75%-24.83M

3.44%-20.29M

-40.28%-23.16M

19.42%-22.77M

27.88%-18.43M

-90.58%-21.01M

-86.08%-16.51M

-238.27%-28.26M

-290.11%-25.55M

-84.81%-11.02M

-47.50%-8.87M

---8.35M

---6.55M

---5.96M

---6.01M

持續經營利潤

-14.13%-41.49M

-19.14%-35.77M

15.98%-30.50M

5.73%-32.59M

-13.74%-36.35M

-20.03%-30.02M

-28.16%-36.31M

-35.67%-34.57M

-39.31%-31.96M

-4.45%-25.01M

-35.89%-28.33M

-2.61%-25.48M

-13.10%-22.94M

-3.39%-23.95M

8.45%-20.85M

-34.75%-24.83M

3.44%-20.29M

-40.28%-23.16M

19.42%-22.77M

27.88%-18.43M

-90.58%-21.01M

-86.08%-16.51M

-238.27%-28.26M

-290.11%-25.55M

-84.81%-11.02M

-47.50%-8.87M

---8.35M

---6.55M

---5.96M

---6.01M

歸属于母公司的淨利潤

-14.13%-41.49M

-19.14%-35.77M

15.98%-30.50M

5.73%-32.59M

-13.74%-36.35M

-20.03%-30.02M

-28.16%-36.31M

-35.67%-34.57M

-39.31%-31.96M

-4.45%-25.01M

-35.89%-28.33M

-2.61%-25.48M

-13.10%-22.94M

-3.39%-23.95M

8.45%-20.85M

-34.75%-24.83M

3.44%-20.29M

-40.28%-23.16M

19.42%-22.77M

27.88%-18.43M

-90.58%-21.01M

-86.08%-16.51M

-238.27%-28.26M

-290.11%-25.55M

-84.81%-11.02M

-47.50%-8.87M

---8.35M

---6.55M

---5.96M

---6.01M

歸屬普通股東的淨利潤

-14.13%-41.49M

-19.14%-35.77M

15.98%-30.50M

5.73%-32.59M

-13.74%-36.35M

-20.03%-30.02M

-28.16%-36.31M

-35.67%-34.57M

-39.31%-31.96M

-4.45%-25.01M

-35.89%-28.33M

-2.61%-25.48M

-13.10%-22.94M

-3.39%-23.95M

8.45%-20.85M

-34.75%-24.83M

3.44%-20.29M

-40.28%-23.16M

19.42%-22.77M

27.88%-18.43M

-90.58%-21.01M

-86.08%-16.51M

-238.27%-28.26M

-290.11%-25.55M

-84.81%-11.02M

-47.50%-8.87M

---8.35M

---6.55M

---5.96M

---6.01M

基本每股收益

17.45%-0.38

19.75%-0.34

42.22%-0.30

32.79%-0.33

-2.42%-0.47

-13.80%-0.42

-4.35%-0.51

-10.40%-0.49

9.59%-0.45

30.07%-0.37

5.21%-0.49

29.25%-0.44

2.19%-0.50

9.58%-0.53

10.11%-0.52

-32.82%-0.63

10.24%-0.51

-30.49%-0.59

31.07%-0.58

43.95%-0.47

-55.38%-0.57

-51.70%-0.45

-949.24%-0.84

74.95%-0.84

-70.09%-0.37

-35.85%-0.30

---0.08

---3.36

---0.22

稀釋每股收益

17.45%-0.38

19.75%-0.34

42.22%-0.30

32.79%-0.33

-2.42%-0.47

-13.80%-0.42

-4.35%-0.51

-10.40%-0.49

9.59%-0.45

30.07%-0.37

5.21%-0.49

29.25%-0.44

2.19%-0.50

9.58%-0.53

10.11%-0.52

-32.82%-0.63

10.24%-0.51

-30.49%-0.59

31.07%-0.58

43.95%-0.47

-55.38%-0.57

-51.70%-0.45

-949.24%-0.84

74.95%-0.84

-70.09%-0.37

-35.85%-0.30

---0.08

---3.36

---0.22

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Oric Pharmaceuticals Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 ORIC 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Oric Pharmaceuticals Inc 全年的淨利潤是多少？



Oric Pharmaceuticals Inc 2025 財年淨利潤為 -129.47M。

Oric Pharmaceuticals Inc 上一季度的淨利潤是多少？



Oric Pharmaceuticals Inc 最近一個季度的淨利潤為 -41.49M。

Oric Pharmaceuticals Inc 年度營業利潤是多少？



Oric Pharmaceuticals Inc 2025 財年的營業利潤為 -143.00M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。